News & Events
For media inquiries email [email protected]
Company news
October 24, 2025
Press Release
Parabilis Medicines Presents Clinical and Preclinical Data Demonstrating Broad Potential of Helicon™ Peptides at AACR-NCI-EORTC 2025
October 17, 2025
Press Release
Parabilis Medicines Presents Clinical Data Demonstrating First-Ever Drugging of Key Cancer Driver with FOG-001
September 3, 2025
Press Release
Parabilis Medicines Appoints Fawzi Benzaghou, M.D., as Chief Medical Officer
Publications and presentations
October 25, 2025
PCF Scientific Retreat
Discovery and Optimization of ERG Bifunctional, Stapled Peptide Degraders using Generative AI–Driven Multi-Property Modeling
October 25, 2025
AACR-NCI-EORTC
Distinct aspects of β-catenin biology drive multiple biologically rational FOG-001 combinations for MSS colorectal cancer
Recent highlights
October 7, 2025
Panel
“Fierce 15 – Where are they now?” Panel at Fierce Biotech Week
Parabilis Chief Business Officer Greg Miller joined the “Fierce 15 – Where are they now?” panel at Fierce Biotech Week – a check in with leaders from companies previously recognized by Fierce as the most promising emerging biotechs pushing the boundaries of science. During the panel, Greg and fellow life science leaders explored topics including partnerships and how companies are building their business models in today’s market. The panel was recorded and published on Fierce’s “The Top Line” podcast.
Upcoming events
November 12, 2025
Boca Raton, FL